For example, the SphK1/SphK2 inhibitor SKi reduces phosphorylated AKT and ERK levels and induces apoptotic death in T-ALL cell lines and primary human patient cells, although some sub-populations are resistant to death. Here, AKT1 is linked to acute lymphoblastic leukemia.